SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037710
Filing Date
2020-08-06
Accepted
2020-08-06 16:02:54
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q spro-10q_20200630.htm   iXBRL 10-Q 3594375
2 EX-10.1 spro-ex101_83.htm EX-10.1 127929
3 EX-10.2 spro-ex102_82.htm EX-10.2 93454
4 EX-10.3 spro-ex103_80.htm EX-10.3 109031
5 EX-10.4 spro-ex104_81.htm EX-10.4 49663
6 EX-31.1 spro-ex311_9.htm EX-31.1 22402
7 EX-31.2 spro-ex312_8.htm EX-31.2 22319
8 EX-32.1 spro-ex321_7.htm EX-32.1 9828
9 EX-32.2 spro-ex322_10.htm EX-32.2 9833
  Complete submission text file 0001564590-20-037710.txt   11582367

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA spro-20200630.xsd EX-101.SCH 75988
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE spro-20200630_cal.xml EX-101.CAL 52480
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE spro-20200630_def.xml EX-101.DEF 241461
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE spro-20200630_lab.xml EX-101.LAB 538284
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spro-20200630_pre.xml EX-101.PRE 402988
15 EXTRACTED XBRL INSTANCE DOCUMENT spro-10q_20200630_htm.xml XML 2066535
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38266 | Film No.: 201081480
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences